FDAClass IIIAugust 14, 2024

Methotrexate Tablets recall

Methotrexate Tablets, USP, 2.5mg, 100-count Bottle, RX Only, Distributed By: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC# 69238-1423-1

Why was Methotrexate Tablets recalled?

Presence of Foreign Tablets: Potential presence of Fludrocortisone Acetate Tablet USP 0.1 mg within the Methotrexate 2.5 mg 100-count Bottle.

What should I do if I have this product?

Review the official FDA enforcement record for current instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot # BB29124, Exp. 02/28/2026

Product
Methotrexate Tablets, USP, 2.5mg, 100-count Bottle, RX Only, Distributed By: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC# 69238-1423-1
Recalling firm
Amneal Pharmaceuticals, LLC
Quantity
12,624 bottles
Distribution
Nationwide in the USA
Recall date
August 14, 2024
Classification
Class III
Status
Completed
Agency
FDA (drug)
Open FDA enforcement record Latest recalls